HIV vaccine efforts are undermined by off-target antibodies
ANI
29 Jul 2021, 13:37 GMT+10
California [US], July 29 (ANI): Some proof-of-concept HIV vaccines in early human trials generate antibodies that actively hinder protection by degrading the vaccine s payload, suggests a new study from Scripps Research.
Their study was published in the journal Science Advances. While scientists have had rapid success engineering vaccines against the pandemic coronavirus in less than a year s time, HIV, the virus responsible for the AIDS epidemic, has proven significantly more challenging.
Understanding how off-target antibodies may be undermining HIV vaccine prototypes allows for design improvements, says the study s lead author, Andrew Ward, PhD, a structural biology professor at Scripps Research in La Jolla, CA.
US Executive Branch Update – July 26, 2021 - Government, Public Sector
mondaq.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mondaq.com Daily Mail and Mail on Sunday newspapers.
A turning point for children: creating an AIDS-free generation
statnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from statnews.com Daily Mail and Mail on Sunday newspapers.
Prevalence and Mortality of Triple-Negative Breast Cancer in West Africa: Biologic and Sociocultural Factors
ascopubs.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ascopubs.org Daily Mail and Mail on Sunday newspapers.